Skip to main content
. 2023 Aug 26;28(12):1064–1071. doi: 10.1093/oncolo/oyad232

Figure 2.

Figure 2.

Recurrence and survival in 232 patients with medullary thyroid carcinoma after surgical management, (A) Overall survival is 82% (95% CI, 76-88) at 5 years and 71% (95% CI, 63-80) at 10 years, (B) Disease-specific survival is 91% (95% CI, 86-96) at 5 years and 87% (95% CI, 81-94) at 10 years, (C) cumulative incidence of local recurrence is 15% (95% CI, 8-20) at 5 years and 25% (16-32) at 10 years, (D) distant recurrence is 12% (95% CI, 6-17) at 5 years and 22% (95% CI, 13-29) at 10 years.